Inventor · disambiguated record
Dieter Heldmann
Also filed as: HELDMANN DIETER
16 granted patents·7 pending applications·772 citations·filing 1990–2021
94Inventor score
Files withSCHERING AG9CONSORTIUM ELEKTROCHEM IND4WACKER CHEMIE AG2BAYER SCHERING PHARMA AG1DIAGNOSTIKFORSCHUNG INST1
Top patents by PatentIndex Score
23 records- 0197US5425366AUltrasonic contrast agents for color Doppler imagingSCHERING AG·Filed 1993·Granted Jun 20, 1995·358 cites·19 claims
- 0291US6068857AMicroparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their productionSCHERING AKTIENGESELLCHAFT·Filed 1994·Granted May 30, 2000·136 cites·23 claims
- 0381US6177062B1Agents and methods for enhancing contrast in ultrasound imagingSCHERING AG·Filed 1995·Granted Jan 23, 2001·76 cites·6 claims
- 0481US6071496APolyalkylcyanoacrylate agents and methods for enhancing contrast in ultrasound imagingSCHERING AG·Filed 1995·Granted Jun 6, 2000·74 cites·35 claims
- 0571US8846808B2Curable organopolysiloxane compositionHELDMANN DIETER·Filed 2011·Granted Sep 30, 2014·2 cites·17 claims
- 0670US6319488B1Contrast medium for near infrared diagnosisDIAGNOSTIKFORSCHUNG INST·Filed 1996·Granted Nov 20, 2001·40 cites·11 claims
- 0769US6709693B1Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxisSCHERING AG·Filed 2000·Granted Mar 23, 2004·16 cites·10 claims
- 0861US6667422B2Process for the preparation of α-haloketonesCONSORTIUM ELEKTROCHEM IND·Filed 2002·Granted Dec 23, 2003·1 cites·14 claims
- 0959US6284280B1Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their productionSCHERING AG·Filed 1999·Granted Sep 4, 2001·19 cites·10 claims
- 1058US6383470B1Microparticle preparations made of biodegradable copolymersFiled 1997·Granted May 7, 2002·20 cites·21 claims
- 1158US2025034178A1Silylbenzopinacol radical initiatorsWACKER CHEMIE AG·Filed 2021·Application pending·0 cites
- 1254US6436365B2Process for therapeutic treatment of proliferative diseasesSCHERING AG·Filed 1998·Granted Aug 20, 2002·7 cites·17 claims
- 1350US2011190246A1Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ringBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1448US2002022004A1Contrast medium for near infrared diagnosisFiled 2001·Application pending·0 cites
- 1547US6264959B1Ultrasonic contrast agents, process for their preparation and their use as a diagnostic and therapeutic agentSCHERING AG·Filed 1990·Granted Jul 24, 2001·9 cites·18 claims
- 1647US2007032694A1Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxisDINKELBORG LUDGER·Filed 2003·Application pending·0 cites
- 1747US2005112690A1Binding molecules for the extra-domain B of fibronectin for detection of arteriosclerotic plaqueFiled 2004·Application pending·0 cites
- 1846US2021292483A1Production of crosslinkable high-molecular silicon resinsWACKER CHEMIE AG·Filed 2017·Application pending·0 cites
- 1944US7081537B2Process for the electrophilic substitution of thiazolidines or oxazolidinesCONSORTIUM ELEKTROCHEM IND·Filed 2004·Granted Jul 25, 2006·0 cites·16 claims
- 2043US6306366B1Microparticles that contain gas, galactose and a saturated fatty acidSCHERING AG·Filed 1998·Granted Oct 23, 2001·8 cites·15 claims
- 2140US6881855B2Norbornyl-substituted silanes and the use thereofCONSORTIUM ELEKTROCHEM IND·Filed 2002·Granted Apr 19, 2005·0 cites·12 claims
- 2240US2006030732A1Process for cleaving thiazolidinesCONSORTIUM ELEKTROCHEM IND·Filed 2005·Application pending·0 cites
- 2337US6488909B1Chelating agents as well as their tricarbonyl complexes with technetium and rheniumSCHERING AG·Filed 1999·Granted Dec 3, 2002·6 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Dieter Heldmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →